Changing pattern of neonatal bacteremia. Microbiology and antibiotic resistance

Saudi Medical Journal

Volumn 25, Issue 12, 2004, Pages 1951-1956

  Ellabib, Mohamed S ^a   Ordonez, Adoracion ^a   Ramali, Asma ^a   Walli, Amala ^a   Benayad, Touria ^a   Shebrlo, Hafida ^a  

^a UNIVERSITY OF TRIPOLI   (Libyan Arab Jamahiriya)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; AZTREONAM; CARBENICILLIN; CEFALORIDINE; CEFOPERAZONE; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; CLAVULANIC ACID; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; FUSIDIC ACID; GENTAMICIN; IMIPENEM; LINCOMYCIN; MACROLIDE; OXACILLIN; PENICILLIN G; PENICILLINASE; PIPERACILLIN PLUS TAZOBACTAM; TIMENTIN; UNINDEXED DRUG; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; BLOOD CULTURE; CANDIDA ALBICANS; COAGULASE NEGATIVE STAPHYLOCOCCUS; COAGULASE POSITIVE STAPHYLOCOCCUS; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE; ENZYME SYNTHESIS; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE SEPSIS; GRAM POSITIVE COCCI; HOST PATHOGEN INTERACTION; HUMAN; KLEBSIELLA PNEUMONIAE; LIBYAN ARAB JAMAHIRIYA; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; MICROBIAL GROWTH; MICROORGANISM DETECTION; NEWBORN; NEWBORN INTENSIVE CARE; NEWBORN MORTALITY; NEWBORN SEPSIS; PANTOEA AGGLOMERANS; PROSPECTIVE STUDY; PSEUDOMONAS; SERRATIA LIQUEFACIENS; SERRATIA MARCESCENS;

ANTI-BACTERIAL AGENTS; BACTEREMIA; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE; ENTEROBACTER; ENTEROBACTERIACEAE INFECTIONS; FEMALE; HUMANS; INTENSIVE CARE, NEONATAL; KLEBSIELLA INFECTIONS; LIBYA; MALE; MICROBIAL SENSITIVITY TESTS; SERRATIA INFECTIONS; STAPHYLOCOCCAL INFECTIONS;

EID: 13844275791     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Garrouste-Orgeas M, Chevert S, Mainardi JL, Timsit JF, Misset B. A one-year prospective study of nosocomial bacteraemia in ICU and non-ICU patients and its impact on patient outcome. J Hosp Infect 2000; 44: 206-213.
2. Lark RL, Chenoweth C, Saint S, Zemencuk JK, Lipsky BA, Plorde J. Four year prospective evaluation of nosocomial bacteremia: epidemiology, microbiology, and patient out come. Diagn Micrbiol Infect Dis 2000; 38: 131-140.
3. Jang TN, Kuo BL, Shen SH, Fung CP, Lee SH, Yang TL, et al. Nosocomial gram-negative bacteremia in critically ill patients: epidemiologic characteristics and prognostic factors in 147 episodes. J Formos Medical Assoc 1999; 98: 465-473.
4. Nambiar S, Singh N. Change in epidemiology of health care-associated infections neonatal intensive care unit. Pediatr Infect Dis J 2002; 21: 839-842.
5. Bromiker R, Arad I, Peleg O, Preminger A, Engelhard D. Neonatal bacteremia: patterns of antibiotic resistance. Infect Control Hosp Epidemiol 2001; 22: 767-770.
6. Koneman EW, Allen SD, Janda WM, Schreckenberger PC, Winn Jr, Washington C. Color Atlas and Text Book of Diagnostic Microbiology. 5th ed. Philadelphia (PA): Lippincott-Raven Press; 1997.
7. National Committee for Clinical Laboratory Standards: Performance Standards for Antimicrobial Disk Susceptibility Tests (Approved Standard, M2-A5). Villanova (PA): National Committee for Clinical Laboratory Standards; 1993.
8. Liu H, Buescher G, Lewis N, Snyder S, Jungkind D. Detection of borderline oxacillin-resistant Staphylococcus aureus and differentiation from methicillin-resistant strains. Eur J Clin Microbiol Infect Dis 1990; 9: 717-724.
9. Joshi SG, Ghole VS, Niphadkar KB. Neonatal gram-negative bacteremia. Indian J Pediatr 2000; 67: 27-32.
10. Aronson MD, Bor D. Blood cultures. Ann Intern Med 1987; 106: 246-253.
11. Eykyn SI, William RG, Philips I. The causative organisms of septicaemia and their epidemiology. J Antimicrob Chemother 1990; 25 (Suppl C): 41-58.
12. Spanu T, Luzzaro F, Perilli M, Amicosante G, Toniolo A, Fadda G, et al. Occurrence of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae in Italy: implications for resistant beta-lactamase and other antimicrobial drugs. Antimicrob Agents Chemother 2002; 46: 196-202.
13. Musoke RN, Revathi G. Emergence of multidrug-resistant gram-negative organisms in a neonatal unit and the therapeutic implications. J Trop Pediatr 2000; 46: 86-91.
14. Kallman J, Kihlstrom E, Sjoberg L, Schollin J. Increase of Staphylococci in neonatal septicaemia: a fourteen-year study. Acta Paediatr 1997; 86: 533-538.
15. Lyytikainen O, Saxen H, Ryhanen R, Vaara M, Vuopio-Varkila J. Persistance of a multiresistant clone of Staphylococcus epidermidis in a neonatal intensive-care unit for a four-year period. Clin Infect Dis 1995; 20: 24-29.
16. Brown DF. Detection of methicillin/oxacillin resistance in Staphylococci. J Antimicrob Chemother 2001; 48 (Suppl 1): 65-70.
17. Gal Z, Kovacs P, Hernadi F, Barabas G, Kiss L, Igloi A, et al. Investigation of oxacillin-hydrolyzing beta-lactamase in borderline methicillin-resistant clinical isolates of Staphylococcus aureus. Chemotherapy 2001; 47: 233-238.